VitamFero adds two new independent members to its Board of Directors

Press Files

Contact press service

Archives

2011
2010
2009
2008
2007
2006
2005
2004
2003
2002

Video library

2012/07/25

VitamFero, a biotechnology company developing anti-parasitic vaccine candidates and located in the Genopole® cluster announces that it has nominated Drs. François Guillemin and Jean-Loup Romet-Lemonne as independent directors to its governing board.

Le javascript est inactif sur votre navigateur. Certaines fonctionnalités de cet outil seront inactives ...

Previous page | Top

Latest News

Genethon receives approval from the UK medicine regulatory agency to start a new clinical trial for an inherited immune (...)

VitamFero signs agreement with Merial to develop new production animal antiparasitic vaccines

Progeria: Discovery of a molecular mechanism that protects neurons from premature aging

VitamFero increases its assets with excellent results for two of its veterinary candidates